SparingVision is a biotechnology company focused on the discovering and development of an innovative, therapeutic approach for treatment of blinding inherited retinal diseases such as retinitis pigmentosa.
People affected by Retinitis pigmentosa
People affected by RP in France
People affected by RP in the World
Mutations in more than 63 genes are known to cause RP
We aim to provide therapeutic solutions to patients suffuring from RP around the world.